CBD Research Blog

Current news, information and legal advances in the world of CBD.

Science

CBD-Drug Interactions: Role of Cytochrome P450

By Adrian Devitt-Lee on September 08, 2015 With cannabidiol (CBD) poised to become widely available in pharmaceutical, nutraceutical, and herbal preparations, medical scientists are taking a closer look at CBD-drug interactions. Read full article...

CBD: The Cinderella Molecule

By Martin A. Lee on February 09, 2017 Originally published in High Times (Feb. 2017) “This changes everything!” That was the immediate reaction of Bay Area journalist Fred Gardner as he stood in the office of Steep Hill Laboratory in Oakland and eyed a chromatogram...

Medical Marijuana for Seizures

A cutting edge paper from three cannabis friendly medical professionals— Dustin Sulak, Russel Saneto, and Bonni Goldstein— outlines case reports and the applications of cannabis medicine for epilepsy and seizure disorders. Cannabis clinicians treating epileptic...

News

As Mastercard Exits Cannabis, There’s a Cash Opportunity

As Mastercard Exits Cannabis, There’s a Cash Opportunity

Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry...

The CBD Regulatory Environment in Europe: Part 1

The CBD Regulatory Environment in Europe: Part 1

This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European...

Alternatives to Bankruptcy for Cannabis Companies: Part 1

Alternatives to Bankruptcy for Cannabis Companies: Part 1

The problems facing the cannabis industry arising from its ongoing status as a federally illegal enterprise are numerous and well documented: 280E tax burdens, limited access to banking, exclusion from capital markets, uneven access to federal intellectual property...

Safety & Compliance in the Absence of Regulatory Clarity & Consistency

Safety & Compliance in the Absence of Regulatory Clarity & Consistency

As the legal landscape surrounding cannabis continues to evolve, the creation of robust, sensible and consistent safety regulations remains stalled. A patchwork of broadly inconsistent state rules and regulations, along with years of federal inaction and policy...

2023 Cannabis Supply Chain Virtual Conference

2023 Cannabis Supply Chain Virtual Conference Click here to watch the recording Agenda Cannabis Packaging Solutions: Navigating Regulations, Quality & Environmental Impact Jack Grover, Founder & CEO, Grove Bags In the cannabis industry, packaging regulations...

Five Ingredients for a Successful Cannabis License Application

Five Ingredients for a Successful Cannabis License Application

In the rapidly evolving cannabis industry, in both new and emerging markets, securing a cannabis license is an essential step to establishing a successful business. However, navigating the application process can be complex, challenging and highly competitive. To help...

California’s Social Equity Fee Waiver – Late Is Better Than Never

California’s Social Equity Fee Waiver – Late Is Better Than Never

In a move that Old Guard California Cannabis viewed with bittersweet appreciation, the Department of Cannabis Control on January 1, 2022 announced it would waive license fees for those cannabis companies impacted by the War on Cannabis. Many pre-2017 operators...

FDA, FTC Issue Warnings to Delta 8 Copycat Cannabis Companies

FDA, FTC Issue Warnings to Delta 8 Copycat Cannabis Companies

Last week, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent out warning letters to six different companies for selling copycat food products that contain Delta-8 THC. In a press release published on July 5, the FDA and FTC said...

Legal